Piwonka R W, Canniff P C, Farah A E
J Cardiovasc Pharmacol. 1983 Nov-Dec;5(6):1058-67.
We studied the actions of amrinone on transmembrane electrical activity in isolated normal and physiologically compromised mammalian cardiac Purkinje and ventricular tissues. No arrhythmogenic effects of amrinone were identified in canine Purkinje tissue superfused with concentrations of 18.7 and 187 micrograms/ml (10(-4) and 10(-3) M) or in feline papillary tissue at concentrations of 18.7 and 56.1 micrograms/ml (10(-4) and 3 X 10(-4)M). In K+-depolarized canine Purkinje tissue, amrinone at 100 micrograms/ml (5.3 X 10(-4) M) failed to restore excitability; however, in norepinephrine-activated, K+-depolarized Purkinje tissue, amrinone significantly increased slow potential upstroke velocity and action potential amplitude and duration at doses ranging from 10 to 300 micrograms/ml. In K+-depolarized canine trabecula carneae, amrinone initiated slow potentials in the absence of norepinephrine and produced dose-dependent increases in slow potential upstroke velocity and in action potential amplitude and duration over a dose range of 30-300 micrograms/ml. Amrinone at 100 micrograms/ml did not influence transmembrane electrical activity of Purkinje tissue with tetracaine-depressed Na+-channel function. Amrinone did not produce oscillatory afterpotentials, influence ouabain-induced afterpotentials, or alter overdrive-induced depolarization. Amrinone caused no distinctly arrhythmia-producing effects in a heterogeneous population of depolarized canine Purkinje tissues removed from canine myocardial infarction, although small changes were observed in some tissues exhibiting slow channel action potentials. These experiments show that amrinone did not influence either Na+-dependent inward currents or Na+-K+ exchange mechanisms. Instead, amrinone facilitated slow channel action potentials in cardiac tissue and thereby could alter cardiac contractility, as well as conduction within reentry circuits in hearts which possess appropriate pathophysiologic substrates.
我们研究了氨力农对离体正常及生理功能受损的哺乳动物心脏浦肯野纤维和心室组织跨膜电活动的作用。在灌流浓度为18.7和187微克/毫升(10⁻⁴和10⁻³摩尔/升)的犬浦肯野纤维组织中,以及在浓度为18.7和56.1微克/毫升(10⁻⁴和3×10⁻⁴摩尔/升)的猫乳头肌组织中,未发现氨力农有致心律失常作用。在钾离子去极化的犬浦肯野纤维组织中,100微克/毫升(5.3×10⁻⁴摩尔/升)的氨力农未能恢复兴奋性;然而,在去甲肾上腺素激活的、钾离子去极化的浦肯野纤维组织中,氨力农在10至300微克/毫升的剂量范围内可显著增加慢电位上升速度、动作电位幅度和时程。在钾离子去极化的犬乳头肌中,氨力农在无去甲肾上腺素的情况下可引发慢电位,并在30至300微克/毫升的剂量范围内使慢电位上升速度、动作电位幅度和时程呈剂量依赖性增加。100微克/毫升的氨力农对具有丁卡因抑制的钠离子通道功能的浦肯野纤维组织的跨膜电活动无影响。氨力农不产生振荡后电位,不影响哇巴因诱导的后电位,也不改变超速驱动诱导的去极化。在从犬心肌梗死处取出的异质性去极化犬浦肯野纤维组织群体中,氨力农未产生明显的致心律失常作用,尽管在一些表现出慢通道动作电位的组织中观察到了微小变化。这些实验表明,氨力农既不影响钠离子依赖性内向电流,也不影响钠钾交换机制。相反,氨力农可促进心脏组织中的慢通道动作电位,从而可能改变心脏收缩力,以及在具有适当病理生理底物的心脏折返环路中的传导。